In the BioHarmony Drug Report Database

"Preview" Icon

Amifampridine

Ruzurgi, Firdapse, Zenas (amifampridine) is a small molecule pharmaceutical. Amifampridine was first approved as Ruzurgi on 2009-12-23. It is used to treat lambert-eaton myasthenic syndrome in the USA. It has been approved in Europe to treat lambert-eaton myasthenic syndrome.

 

Trade Name

 

Firdapse, Zenas
 

Common Name

 

amifampridine
 

ChEMBL ID

 

CHEMBL354077
 

Indication

 

lambert-eaton myasthenic syndrome
 

Drug Class

 

Image (chem structure or protein)

Amifampridine structure rendering